NL-OMON29491
Recruiting
Not Applicable
Sickle Cell Outcome REsearch (SCORE)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- A
- Enrollment
- 1000
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •A diagnosis of SCD of any genotype;
- •\- Written informed consent by the patient or legal guardians, and pediatric consent when indicated.
Exclusion Criteria
- •\- Any medical or social reason, which obstructs or inhibits study participation according to treating physician;
- •\- Patient or legal guardians unable or unwilling to give consent, or lack of pediatric consent when indicated.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Sickle Cell Outcome REsearchNL-OMON55241Erasmus MC, Universitair Medisch Centrum Rotterdam1,000
Not yet recruiting
Phase 4
A study that helps in Observing patients suffering from Sickle Cell Disease, when given a treatment of crizanlizumab in Middle Eastcountries and India (SPOTLIGHT)CTRI/2022/06/043467ovartis Healthcare Pvt Ltd
Recruiting
Phase 3
Long-term Follow-up of Subjects With Sickle Cell Disease Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector2024-513901-30-00Bluebird Bio Inc.3
Recruiting
Phase 1
ong-term Follow-up of Subjects With Sickle Cell Disease Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral VectorCTIS2024-513901-30-00Bluebird Bio Inc.88
Terminated
Not Applicable
Prospective, Observational Study in Sickle Cell Disease Patients on Crizanlizumab Treatment in Middle East Countries and IndiaSickle Cell DiseaseNCT05020873Novartis Pharmaceuticals44